Barnett, 2007 n= 14,029; >65 yo with dementia; Data per VA and Medicare databases; Followed 18 months (2002-2003) olanzapine, risperidone, or quetiapine vs. conventional agents Inpatient admission ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Older patients ...
Adjunctive use of xanomeline/trospium chloride (Cobenfy) offered no statistically significant benefit over placebo in adults with symptoms of schizophrenia inadequately controlled by an atypical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results